Clinical Chemistry Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 50: 1963-1965, 2004; 10.1373/clinchem.2004.039784
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ugozzoli, L. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ugozzoli, L. A.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Automation and Analytical Techniques
(Clinical Chemistry. 2004;50:1963-1965.)
© 2004 American Association for Clinical Chemistry, Inc.


Editorials

Multiplex Assays with Fluorescent Microbead Readout: A Powerful Tool for Mutation Detection

Luis A. Ugozzoli

1 Gene Expression Division, Life Science Group, Bio-Rad Laboratories, Hercules, CA

The first 300 words of the full text of this article appear below.

After the completion of the Human Genome Project, the goal for biomedical research is to apply genomic approaches for the improvement of human health (1). The study of human DNA variation promises to have a great impact on understanding how genetic factors contribute to human disease, conferring susceptibility or resistance; it is also expected to help uncover the reasons that individuals respond differentially to therapeutics.

Technologies for mutation detection can be classified into methods for the detection of unknown mutations and methods for the detection of known mutations (2). Methods for the detection of unknown mutations (3)(4)(5)(6)(7)(8), also known as screening or scanning methods, are used during the discovery phase. Once a new mutation associated with a genetic disease has been characterized and validated, it is usually detected over and over in many DNA samples by specific, cost-efficient, and easy-to-use methods (9)(10)(11)(12)(13), also known as "diagnostic methods" (14).

Typically, genotyping assays for known mutations start with sample preparation followed by amplification of the target DNA sequence containing the mutation to be tested. This latter step is most commonly accomplished by use of the PCR, but other amplification strategies are available (15)(16)(17). Subsequently, the presence or absence of the mutation is determined by allele-specific biochemical reactions. The selected allele-specific method largely determines the specificity, accuracy, and reproducibility of the genotyping assay. The discriminating power of DNA ligases (13)(15) and DNA polymerases (10)(11)(12), as well as the difference in thermodynamics between matched and mismatched DNA duplexes (9), has been extensively exploited for mutation detection. The final . . . [Full Text of this Article]




The following articles in journals at HighWire Press have cited this article:


Home page
J. Clin. Microbiol.Home page
Y.-C. Lin, W.-H. Sheng, S.-C. Chang, J.-T. Wang, Y.-C. Chen, R.-J. Wu, K.-C. Hsia, and S.-Y. Li
Application of a Microsphere-Based Array for Rapid Identification of Acinetobacter spp. with Distinct Antimicrobial Susceptibilities
J. Clin. Microbiol., February 1, 2008; 46(2): 612 - 617.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Association for Clinical Chemistry.